Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections.

[1]  B. Branson,et al.  Evaluation of the performance characteristics of 6 rapid HIV antibody tests. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  L. Torian,et al.  HIV type 2 in New York City, 2000-2008. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  B. Branson,et al.  2010 HIV Diagnostics Conference , 2010, Expert review of anti-infective therapy.

[4]  M. Wainberg,et al.  Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2 , 2009, Antimicrobial Agents and Chemotherapy.

[5]  M. Kalish,et al.  Alternative Algorithms for Human Immunodeficiency Virus Infection Diagnosis Using Tests That Are Licensed in the United States , 2008, Journal of Clinical Microbiology.

[6]  S. Peel,et al.  Multispot™ HIV-1/HIV-2 Rapid Test: advantages over other rapid HIV tests , 2007, Expert review of molecular diagnostics.

[7]  A. MacNeil,et al.  Direct Evidence of Lower Viral Replication Rates In Vivo in Human Immunodeficiency Virus Type 2 (HIV-2) Infection than in HIV-1 Infection , 2007, Journal of Virology.

[8]  J. Albert,et al.  Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. , 2000, Archives of internal medicine.

[9]  S. Popper,et al.  Low Plasma Human Immunodeficiency Virus Type 2 Viral Load Is Independent of Proviral Load: Low Virus Production In Vivo , 2000, Journal of Virology.

[10]  S. Popper,et al.  Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. , 1999, The Journal of infectious diseases.

[11]  A. Williams,et al.  Identification and characterization of an HIV‐2 antibody‐positive blood donor in the United States , 1998, Transfusion.

[12]  R. Janssen,et al.  Absence of human immunodeficiency virus type 2 infection among patients in a hospital serving a New York community at high risk for infection. Centers for Disease Control and Prevention/Bronx‐Lebanon Hospital Center HIV Serosurvey Team , 1996, Transfusion.

[13]  H. Zaaijer,et al.  Early detection of antibodies to HIV-1 by third-generation assays , 1992, The Lancet.

[14]  T. O'Brien,et al.  Testing for antibodies to human immunodeficiency virus type 2 in the United States. , 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[15]  T. O'Brien,et al.  Human immunodeficiency virus type 2 infection in the United States. Epidemiology, diagnosis, and public health implications. , 1992, JAMA.

[16]  M. Lafontaine,et al.  Cross-reactivity on western blots in HIV-1 and HIV-2 infections. , 1991, AIDS.

[17]  K. D. de Cock,et al.  Epidemiology of HIV‐2 infection , 1989, AIDS.

[18]  髙折 晃史,et al.  19th Conference on Retroviruses and Opportunistic Infections , 2012 .